bioRxivBioinformaticsPreprint
Improving Drug Sensitivity Prediction and Inference by Multitask Learning
Abstract
The development of models to predict sensitivity to anticancer drugs is an area of significant interest, given the diverse responses to treatment among patients and the considerable expense and time involved in anticancer drug development. Leveraging "omic" data and anticancer response information from the Cancer Cell Line Encyclopedia, we propose a novel approach utilizing multitask learning to enhance prediction accuracy and inference. We extended a multitask learning framework called the Data Shared Lasso to develop the Data Shared Elastic Net. This enabled the construction of tissue-specific models with information sharing while maintaining the attractive properties of Elastic Net regression. By employing this approach, we observed improvements in prediction accuracy compared to single-task Elastic Net models, particularly for cell lines displaying high sensitivity to treatment. Furthermore, the Data Shared Elastic Net facilitated the identification of predictors for anticancer drug sensitivity within specific tissue types, shedding light on cellular pathways targeted by these drugs across tissues. We also investigated the impact of data leakage on modeling outcomes from previous studies, which led to underestimating prediction error and erroneous inferences
- organism: human
- assay: bulk RNA-seq
- research focus: drug response / drug discovery
- research focus: differential expression
- research focus: benchmarking
- approach: machine learning (classical)
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Two-step multi-omics modelling of drug sensitivity in cancer cell lines to identify driving mechanisms
Nina Kusch, Andreas Schuppert·PLoS ONEPeer-reviewed·Nov 23, 2020
- Tissue-aware elastic net decomposition reveals shared and lineage-specific drug response biomarkers
Jared Strauch, Leila Azinfar, … Amir Asiaee·bioRxiv·Jun 25, 2026
- Dr.Paso: Drug response prediction and analysis system for oncology research
Francisco J Azuaje, Tony Kaoma, … Simone P. Niclou·bioRxiv·Dec 21, 2017
- PathPCNet: Pathway Principal Component-Based Interpretable Framework for Drug Sensitivity Prediction
Bikhyat Adhikari, Masrur Sobhan, … Ananda Mohan Mondal·bioRxiv·Aug 20, 2025
- Multi-task deep latent spaces for cancer survival and treatment response prediction
Teemu Rintala, Francesco Napolitano, Vittorio Fortino·BioinformaticsPeer-reviewed·Jun 17, 2024
- Learning and actioning general principles of cancer cell drug sensitivity
Francesco Carli, Pierluigi Di Chiaro, … Francesco Raimondi·Nature CommunicationsPeer-reviewed·Feb 14, 2025